COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study

被引：4
|
作者：
Erden, A. [1 ,2 ]
Karakas, O. [1 ,2 ]
Armagan, B. [1 ,2 ]
Guven, S. C. [1 ,2 ]
Ozdemir, B. [1 ,2 ]
Atalar, E. [1 ,2 ]
Apaydin, H. [1 ,2 ]
Usul, E. [1 ,3 ]
Ates, I [1 ,4 ]
Omma, A. [1 ,2 ]
Kucuksahin, O. [1 ,5 ]
机构：
[1] Ankara Sehir Hastanesi, MH6 Onkol Binasi, Romatol Bolumu, TR-06800 Ankara, Turkey
[2] Minist Hlth, Clin Rheumatol, Ankara City Hosp, Ankara, Turkey
[3] Sincan Dr Nafiz Korez State Hosp, Clin Emergency Med, Ankara, Turkey
[4] Univ Hlth Sci, Minist Hlth, Sch Med, Dept Internal Med,Ankara City Hosp, Ankara, Turkey
[5] Ankara Yildirim Bayezit Univ, Sch Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey
来源：
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2022年 / 123卷 / 02期
关键词：
antiphospholipid syndrome; COVID-19; outcome; thrombosis; mortality; INTERNATIONAL CONSENSUS STATEMENT; CLASSIFICATION CRITERIA; MECHANISMS;
D O I：
10.4149/BLL_2022_018
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BACKGROUND: Aim of this study is to investigate COVID-19 outcomes in patients with antiphospholipid syndrome (APS). METHODS: A retrospective cohort was formed from APS patients. Patients were screened for a record of positive SARS-CoV 2 PCR. In PCR-positive patients, clinical data and information regarding COVID-19 outcomes were collected from medical records. RESULTS: A positive PCR test was detected in 9/53 APS patients, while 66.7 %, 33.3 % and 11.1 % of APS patients with COVID-19 were under hydroxychloroquine, LMWH or warfarin, and acetylsalicylic acid, respectively. There were 3/9 patients found to be hospitalized and one died. No new thrombotic event was reported in any of the patients during COVID-19 infection. CONCLUSION: Baseline use of hydroxychloroquine, antiaggregants and anticoagulants may be associated with an absence of new thrombotic event (Tab. 2, Ref. 33). Text in PDF www.elis.sk
引用
收藏
页码：120 / 124
页数：5
相关论文
共 50 条
  • [1] Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study
    Karakas, Ozlem
    Erden, Abdulsamet
    Armagan, Berkan
    Guven, Serdar Can
    Atalar, Ebru
    Polat, Bunyamin
    Omma, Ahmet
    Kucuksahin, Orhan
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (02) : 292 - 297
  • [2] Comment on evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study
    Tsai, Wen Han
    Liaw, Yung-Po
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (09) : 1869 - 1869
  • [3] EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY.
    Karakas, O.
    Erden, A.
    Armagan, B.
    Guven, S. C.
    Atalar, E.
    Polat, B.
    Omma, A.
    Kucuksahin, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 960 - 960
  • [4] Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study
    van Gerwen, Maaike
    Alsen, Mathilda
    Little, Christine
    Barlow, Joshua
    Naymagon, Leonard
    Tremblay, Douglas
    Sinclair, Catherine F.
    Genden, Eric
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [5] COVID-19 related treatment and outcomes among COVID-19 ICU patients: A retrospective cohort study
    Assiri, Abdullah
    Iqbal, Mir J.
    Mohammed, Atheer
    Alsaleh, Abdulrhman
    Assiri, Ahmed
    Noor, Adeeb
    Nour, Redhwan
    Khobrani, Moteb
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2021, 14 (09) : 1274 - 1278
  • [6] Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study
    Mendel, Arielle
    Fritzler, Marvin J.
    St-Pierre, Yvan
    Rauch, Joyce
    Bernatsky, Sasha
    Vinet, Evelyne.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2023, 7 (01)
  • [7] COVID-19 CHALLENGE IN THE ANTIPHOSPHOLIPID SYNDROME - AN OBSERVATIONAL STUDY OF A SERBIAN COHORT
    Djokovic, A.
    Stojanovich, L.
    Stanisavljevic, N.
    Djokic, S.
    Colic, D.
    Skrijelj, D.
    Soldatovic, I.
    Matic, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1891 - 1891
  • [8] COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study
    Guven, Serdar Can
    Erden, Abdulsamet
    Karakas, Ozlem
    Armagan, Berkan
    Usul, Eren
    Omma, Ahmet
    Kucuksahin, Orhan
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (04) : 715 - 719
  • [9] COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study
    Serdar Can Güven
    Abdulsamet Erden
    Özlem Karakaş
    Berkan Armağan
    Eren Usul
    Ahmet Omma
    Orhan Küçükşahin
    Rheumatology International, 2021, 41 : 715 - 719
  • [10] COVID-19 Outcomes in Hospitalized Patients With Neurodegenerative Disease A Retrospective Cohort Study
    Patel, Roshni Abee
    Stebbins, Glenn T.
    Kishen, Ekta B.
    Barton, Brandon
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (01) : 43 - 51
12345